Recent advances in stem cell biology have established the feasibility of reprogramming human and murine fi broblast cells into induced pluripotent stem (iPS) cells [1] [2] [3] . Th e ectopic expression of four transcription factors (Oct4, Sox2, c-Myc, and Klf4) in fi broblasts was shown to be effi cacious in the conversion of fi broblast cells into embryonic stem (ES) cell-like status. Generation of iPS cells ushers in a new era in reprogramming diff erentiated somatic cells, including fi broblasts, neural cells, liver cells, stomach cells, and blood cells, into ES cell-like stem cells [4] . With the progress of iPS technology, the concept of 'master regulators' , defi ned as a group of major reprogramming factors playing a critical role in the management of cell status of 'pluripotent' versus 'diff erentiated' , has been demonstrated. Th e group of master regulators for iPS cell generation is found to be eff ective with only three genes [5] , which is far fewer than the hundreds or thousands of genes that were presumed to be involved in the determination of cell fate or status.
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Recent advances in stem cell biology have established the feasibility of reprogramming human and murine fi broblast cells into induced pluripotent stem cells. Three master regulators have been demonstrated to be suffi cient in the management of cell status of 'pluripotent' versus 'diff erentiated' . The same strategy has been used to directly convert one somatic cell type into another cell type, such as the converting of exocrine pancreas cells into cells closely resembling beta cells and the reprogramming of fi broblast cells into functional neuron cells. Srivastava's group reported the fi rst direct reprogramming of mouse fi broblast cells into mesoderm lineage cells (cardiomyocytes) with the enforced expression of three cardiac transcriptional factors: Gata4, Mef2c, and Tbx5. The induced cardiomyocytes exhibit a global gene expression profi le and basic electrophysiological characteristics similar to those of postnatal cardiomyocytes. This study made signifi cant advances in cardiovascular and stem cell fi elds and has important implications in understanding heart developmental biology as well as in potential therapies of human cardiovascular diseases.
cardio myo cytes. Th e iCMs also gain an epigenetic status similar to that of cardiomyocytes, indicating that the fi broblasts were epigenetically converted to cardiomyocytelike cells.
Considering the possibility that iCMs could be derived from the subtle heart progenitor cells existing within the Th y1 + /αMHC-GFP − cardiac fi broblast cells, Srivastava's group induced iCMs from mouse tail dermal fi broblast cells as well as from the Th y1 + /αMHC-GFP − /c-kit − , Isl1-YFP/Th y1 + , and Mesp1-YFP − /Th y1 + fi broblast cells. c-kit, Isl1, and Mesap1 have been used as markers of the cardiac progenitor cells and the early mesodermal cells before cardiac commitment. Direct reprogramming of iCMs from the above fi broblast cells strongly supported the view that iCMs originated from diff erentiated fi broblast cells, not from a subpopulation of heart progenitors. Most interestingly, the iCMs exhibit electrophysiological characteristics resembling those of adult ventricular cardiomyocytes. As human ES cell-and iPS cell-derived cardiomyocytes show phenotypes of fetal cardiomyocytes [9, 10] , the adult cardiomyocyte-like characteristics of iCMs could provide more clues in understanding how to induce ES cell-and iPS cell-derived cardiomyocytes into a mature status.
Th is paper paved the way for the generation of a large number of cardiomyocyte-like cells and has important implications in understanding heart developmental biology as well as in the potential therapies of human cardiovascular diseases. For example, global knockouts of key cardiac transcriptional factors, such as Isl1 [11] , exhibit embryonic lethality. Whether iCMs could be induced from fi broblast cells of the global knockout embryos and whether the effi ciency of iCMs could be aff ected by the knockout genes are very interesting questions in the fi eld of developmental biology. Th is paper [8] also reported that cardiac fi broblast cells can give rise to a much higher frequency of iCMs than the tail fi broblast cells can. Determining whether the 'tissue memory' aff ects the reprogramming and elucidating what the mechanism is would also be interesting questions. Th e future genera tion of iCMs from humans, especially from patients with genetically caused cardiovascular diseases, would provide a unique system in which to understand those inherited diseases. However, there are still some issues to be addressed in the direct reprogramming of iCMs. Th e fi rst is how closely the iCMs can resemble the electro physiological characteristics of adult cardiomyocytes. Activation of the Ca 2+ channel in iCMs was reported. How about the activities of K + and Na + channels in iCMs? Second, this paper reported the induction of approxi mately 25% of αMHC-GFP + cells, and only 5% to 6% of cTNT + cardiomyocytes after the direct repro gram ming. Future studies need to improve the repro gramming effi ciency. Th e third is whether ectopic expression of the three reprogramming factors in the adult mouse heart will lead to the abnormal formation of cardiac myocytes in vivo and whether heart stem cells could be activated through a similar mechanism. Th e fourth is whether iCMs from mouse heart disease models, such as models of hypertrophic cardiomyopathy and arrhythmias, will exhibit similar in vivo disease phenotypes.
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